Page results
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
The Chartered Society of Physiotherapy (CSP) has announced that it will take industrial action on Thursday 26 January. As a result, its members that work at UCLH will be on strike on this day. CSP members will also be taking strike action on Thursday 9 Feb, though we are yet to hear if this will take place at UCLH.
-
All patients will undergo an ultrasound scan, which will be performed by a sonographer.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided cervical (neck) and lumbar (lower back) nerve root injections to patients referred by the Camden community MSK services.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided cervical (neck) and lumbar (lower back) facet joint injections to patients referred by the Camden community MSK services.
-
A guide to choosing diabetes technology for UCLH patients
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
File results
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes